The IPO subscription for SHOUGANG LANZA (02553), a leader in the CCUS industry, concluded on May 29. Market sentiment was exceptionally strong, with the public offering portion attracting a staggering HK$77.592 billion in margin financing from brokerages, according to data. Based on a public offering fundraising amount of HK$68.4 million, this represents an oversubscription of approximately 1,133.38 times. Futu Securities led the way with HK$44.847 billion, followed by Phillip Securities and Tiger Brokers with HK$16.1 billion and HK$7.457 billion, respectively, demonstrating robust support from major brokerages.

The company is conducting a global offering of 40 million H shares, with 10% allocated for the Hong Kong public offering and a 15% over-allotment option. SHOUGANG LANZA is expected to list on the Hong Kong Stock Exchange at 9:00 AM on June 3.

As the first company in the CCUS (Carbon Capture, Utilization, and Storage) sector to commercialize and scale the production of low-carbon products using proven synthetic biology technology, SHOUGANG LANZA holds a dominant market position, accounting for 58.4% of the global market share by 2025 revenue. The company possesses dual core technologies of "first-generation carbon reduction and second-generation carbon-negative" processes, directly converting industrial off-gases from steel and ferroalloy production into high-value products like ethanol and microbial protein. Its core technology has received international RSB certification and is recognized by the International Energy Agency as a "successful case of advanced transport biofuels."

The company holds the first domestic "production permit" for feed protein, opening a second growth avenue with SAF. Its microbial protein product has obtained the first domestic new product certificate for feed ingredients from the Ministry of Agriculture and Rural Affairs, boasting a crude protein content exceeding 80%, which is over 15% higher than fishmeal. Concurrently, the company is actively positioning itself in the Sustainable Aviation Fuel (SAF) sector. Its first SAF facility, with an annual capacity of approximately 50,000 tons, is expected to commence operations in 2027, entering the global SAF market, which is projected to grow at a compound annual growth rate of 41.6% from 2025 to 2030.

Prior to listing, SHOUGANG LANZA has secured strategic investments from renowned domestic and international institutions, including Caofeidian Fund, Mitsui & Co., and Shanghai Guoping. On the production capacity front, the Hebei Shoulang Phase II project, utilizing second-generation carbon-negative technology, is expected to begin trial production in June 2026, achieving a carbon fixation rate of 93.5%.

Against the backdrop of intensifying "dual carbon" policies and the mainstreaming of ESG investing, SHOUGANG LANZA, with its unique technological barriers and clear commercialization pathway, presents significant long-term value for tracking.